Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Nature Communications|May 23, 2025
Enhancing the potency of in vivo lentiviral vector mediated gene therapy to hepatocytesCesare Canepari, Michela Milani, Chiara Simoni, et al.Ecancermedicalscience|May 20, 2015
VIN usual type-from the past to the futureMario Preti, Sarah Igidbashian, Silvano Costa, et al.The Journal of Clinical Investigation|March 25, 2009
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyEugenio Montini, Daniela Cesana, Manfred Schmidt, et al.EMBO Molecular Medicine|August 30, 2021
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responsesAdele Mucci, Gabriele Antonarelli, Carolina Caserta, et al.BMJ Open|August 13, 2025
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease researchMarco Ripa, Laura Galli, Paola Cinque, et al.Stem Cells Translational Medicine|February 14, 2017
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic LeukodystrophyVasco Meneghini, Giacomo Frati, Davide Sala, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 27, 2013
Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4Andrea Volonté, Tiziano Di Tomaso, Michela Spinelli, et al.Blood|July 13, 2006
Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defectsAlessandra Mortellaro, Raisa Jofra Hernandez, Matteo M Guerrini, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodesAngelo A Manfredi, Annalisa Capobianco, Antonio Esposito, et al.Nature Medicine|May 30, 2018
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cellsMargherita Norelli, Barbara Camisa, Giulia Barbiera, et al.Pageof 11